Close Menu

NEW YORK (GenomeWeb) – Is it possible to craft a framework for regulating diagnostics that pleases everyone? A small group of labs and test manufacturers has taken a shot at it by coming up with its own proposal for regulating so-called in vitro clinical tests that it hopes will be an acceptable compromise for industry players that often disagree on the regulation of laboratory-developed tests (LDTs).

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new blood test might be able to detect the presence of some 50 cancers, according to New Scientist.

Undark looks into how coronavirus-related shutdowns are affecting field researchers.

In PNAS this week: strategies to design DNA oligonucleotide probes for bacteria, Vibrio cholerae evolution in Haiti, and more.

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.